Core Laboratories (CLB) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Core Laboratories

NYSE•Energy•Oil & Gas Equipment & Services

$12.54+0.01(<0.01%)Pre-market

Market Cap

$562.49M

P/E

23.1x

P/S

1.1x

P/B

2.1x

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

How this company scores

AverageMetricSide Score: 54/100

Strongest: Balance Sheet & Red Flags (19/25); weakest: Growth (10/25).

Profitability11/25

Growth10/25

Balance Sheet & Red Flags19/25

Cash & Earnings Quality14/25

Strengths

Low leverageConsistent free cash flowImproving leverageImproving margins

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 23.1x5y range 18.1x – 31.5x

Currently near its 10-quarter median.

P/S · 1.1x5y range 1.0x – 1.5x

Currently near its 10-quarter median.

P/B · 2.1x5y range 2.1x – 3.8x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Watch

Operating margins declined 12.5% — watch for continued compression, which may signal competitive or cost pressure.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 4 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $562.49M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $519.18M
Q. Revenue: $124.61M
TTM EBITDA: $62.65M
TTM Op. Income: $47.80M
Q. Op. Income: $9.15M
TTM Net Income: $24.35M
Q. Net Income: $5.96M
EPS: $0.13
Shares Out.: $46.03M

$519.18M in TTM revenue grew 0.3% YoY, reaching $124.61M last quarter. TTM EBITDA of $62.65M and TTM operating income of $47.80M show growth is flowing through to the bottom line. TTM net income of $24.35M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has fallen for 2 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 18.6%
EBITDA Margin: 10.4%
Op. Margin: 7.3%
Net Margin: 4.8%

Op. margin of 7.3% is down 4.4% YoY — costs are rising relative to revenue. Net margin at 4.8% and gross margin of 18.6% show how much of each revenue dollar survives to profit. Over the past year, operating margin is down 37% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 23.1x
P/S Ratio: 1.1x
P/B Ratio: 2.1x

At 23.1x P/E, the stock trades within typical market levels. P/S of 1.1x and P/B of 2.1x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is up 27% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $586.78M
Cash: $22.73M
Long-Term Debt: $113.86M
Book Value: $272.67M
D/E Ratio: 0.4
Debt/EBITDA: 8.8

With $586.78M in assets and $113.86M in long-term debt, D/E is 0.4and book value is $272.67M — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 12% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $7.81M
TTM Free Cash Flow: $15.14M
FCF Margin: 2.9%
FCF / Net Income: 0.6

TTM FCF of $15.14M on $7.81M in operating cash flow. The FCF / Net Income ratio of 0.6x means cash covers only part of net income — earnings quality needs attention. Across the last 8 quarters, free cash flow has fallen for 5 consecutive quarters — a weakening trend.